| C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GCLM mRNA" | 27071940 |
| C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GCLM mRNA]" | 27071940 |
| C012277 | 1,2-diamino-4-nitrobenzene | "1,2-diamino-4-nitrobenzene results in increased expression of GCLM mRNA" | 26198647 |
| C039411 | 1,2-dibromo-2,4-dicyanobutane | "1,2-dibromo-2,4-dicyanobutane results in increased expression of GCLM mRNA" | 23999411|2796514 |
| C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA" | 22495766 |
| C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione affects the expression of GCLM mRNA" | 19162173 |
| C576882 | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone results in increased expression of GCLM mRNA | 25596134 |
| C033489 | 1,3-dichloro-2-propanol | "1,3-dichloro-2-propanol results in increased expression of GCLM mRNA" | 26143167 |
| C403008 | 1,4-dihydroquinone | "1,4-dihydroquinone results in increased expression of GCLM mRNA" | 27965148 |
| C015262 | 1,6-hexamethylene diisocyanate | "1,6-hexamethylene diisocyanate results in increased expression of GCLM mRNA" | 24211530 |
| C118701 | 1-bromohexane | 1-bromohexane results in increased expression of GCLM mRNA | 27965148 |
| C118559 | 1-bromopropane | 1-bromopropane results in increased expression of GCLM mRNA | 20211940 |
| C118559 | 1-bromopropane | NFE2L2 promotes the reaction [1-bromopropane results in increased expression of GCLM mRNA] | 20211940 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GCLM mRNA" | 23829299 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GCLM mRNA" | 25614096 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "[2,2',4,4'-tetrabromodiphenyl ether co-treated with 2-tert-butylhydroquinone] results in increased expression of GCLM mRNA" | 25305463 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GCLM mRNA" | 25305463 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "GCLM protein affects the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased cleavage of CASP3 protein]" | 25797475 |
| C019273 | 2,2-bis(4-glycidyloxyphenyl)propane | "2,2-bis(4-glycidyloxyphenyl)propane results in increased expression of GCLM mRNA" | 27965148 |
| C063002 | 2,3-dimethoxy-1,4-naphthoquinone | "[GCLM protein results in decreased susceptibility to domoic acid] which results in decreased susceptibility to 2,3-dimethoxy-1,4-naphthoquinone" | 23315585 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased expression of GCLM protein] | 26577515|2668657 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid results in increased expression of GCLM mRNA] | 19073151 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of GCLM protein | 16972261 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of GCLM mRNA | 19073151 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA]] | 25895139 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "2,5,2',5'-tetrachlorobiphenyl results in increased expression of GCLM mRNA" | 23829299 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene results in increased expression of GCLM mRNA" | 20406850 |
| C499326 | 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide | 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide results in decreased expression of GCLM mRNA | 20159942 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide results in increased expression of GCLM mRNA | 22851183 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide results in increased expression of GCLM mRNA | 22851183 |
| C091423 | 2-chloromethylpyridine | 2-chloromethylpyridine results in increased expression of GCLM mRNA | 26198647 |
| C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of GCLM mRNA" | 22746536 |
| C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of GCLM protein" | 22746536 |
| C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "NFE2L2 gene mutant form inhibits the reaction [2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of GCLM mRNA]" | 22746536 |
| C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of GCLM mRNA" | 22746536 |
| C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of GCLM protein" | 22746536 |
| C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide results in increased expression of GCLM mRNA" | 22746536 |
| C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "NFE2L2 gene mutant form inhibits the reaction [(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide results in increased expression of GCLM mRNA]" | 22746536 |
| C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide results in increased expression of GCLM mRNA" | 22746536 |
| C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide results in increased expression of GCLM protein" | 22746536 |
| C036758 | 2-ethylhexyl acrylate | 2-ethylhexyl acrylate results in increased expression of GCLM mRNA | 27965148 |
| C018855 | 2-tert-butylhydroquinone | "[2,2',4,4'-tetrabromodiphenyl ether co-treated with 2-tert-butylhydroquinone] results in increased expression of GCLM mRNA" | 25305463 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of GCLM mRNA] | 24632381 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of GCLM mRNA | 12081989|2500366 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of GCLM mRNA | 12007577|1601473 |
| C018855 | 2-tert-butylhydroquinone | NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of GCLM mRNA] | 19328227 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of GCLM mRNA | 10978506 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of GCLM promoter | 20810208 |
| C561055 | 2-trifluoromethyl-2'-methoxychalone | 2-trifluoromethyl-2'-methoxychalone results in increased expression of GCLM mRNA | 21539383 |
| C561055 | 2-trifluoromethyl-2'-methoxychalone | 2-trifluoromethyl-2'-methoxychalone results in increased expression of GCLM mRNA | 21539383 |
| C050224 | 3,5,5-trimethylhexanoylferrocene | "3,5,5-trimethylhexanoylferrocene results in increased expression of GCLM protein" | 22649188 |
| C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM protein | 23535287 |
| C021338 | 3-hydroxybenzo(a)pyrene | 3-hydroxybenzo(a)pyrene results in increased expression of GCLM mRNA | 26238291 |
| C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of GCLM mRNA | 28790194 |
| C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of GCLM mRNA] | 28790194 |
| C471109 | 4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline | "4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline results in decreased expression of GCLM mRNA" | 20159942 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [arsenite results in increased expression of GCLM mRNA] | 19328227 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Mercuric Chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C517041 | (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | "(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of GCLM mRNA" | 19561079 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased expression of GCLM mRNA | 19191707 |
| C549066 | 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine | "4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine results in decreased expression of GCLM mRNA" | 20159942 |
| C498826 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide results in increased expression of GCLM mRNA | 23883479 |
| C498826 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | arsenic trioxide promotes the reaction [4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide results in increased expression of GCLM mRNA] | 23883479 |
| C027563 | 4-nitrobenzyl bromide | 4-nitrobenzyl bromide results in increased expression of GCLM mRNA | 23999411 |
| C114459 | 4-phenyl-2-propionamidotetraline | 4-phenyl-2-propionamidotetraline inhibits the reaction [Melatonin inhibits the reaction [KL mutant form results in decreased expression of GCLM mRNA]] | 25550330 |
| C090933 | 4-phenyl-3-furoxancarbonitrile | 4-phenyl-3-furoxancarbonitrile results in increased expression of GCLM mRNA | 22851183 |
| C029728 | 4-phenylenediamine | 4-phenylenediamine results in increased expression of GCLM mRNA | 16314067|2399941 |
| C029370 | 4-toluidine | 4-toluidine results in increased expression of GCLM mRNA | 27638505 |
| C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in increased expression of GCLM protein" | 19121294 |
| C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in increased expression of GCLM protein" | 19121294 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Mercuric Chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C111984 | 6-methylsulfinylhexyl isothiocyanate | 6-methylsulfinylhexyl isothiocyanate results in increased expression of GCLM protein | 21382770 |
| C077646 | 7,12-benz(a)anthraquinone | "7,12-benz(a)anthraquinone results in increased expression of GCLM mRNA" | 23684558 |
| C030735 | 7-aminocephalosporanic acid | 7-aminocephalosporanic acid results in increased expression of GCLM mRNA | 24211530 |
| C020738 | 9,10-dihydro-9,10-dihydroxybenzo(a)pyrene | "9,10-dihydro-9,10-dihydroxybenzo(a)pyrene results in increased expression of GCLM mRNA" | 26238291 |
| C037112 | 9-deoxy-delta-9-prostaglandin D2 | 9-deoxy-delta-9-prostaglandin D2 results in increased expression of GCLM mRNA | 18332871 |
| C037112 | 9-deoxy-delta-9-prostaglandin D2 | 9-deoxy-delta-9-prostaglandin D2 results in increased expression of GCLM protein | 18332871 |
| C023710 | abietic acid | abietic acid results in increased expression of GCLM mRNA | 27965148 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of GCLM mRNA | 25064622 |
| D000082 | Acetaminophen | [Acetaminophen co-treated with Quercetin] results in increased expression of GCLM mRNA | 25881548 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of GCLM mRNA | 21420995|2906747 |
| D000082 | Acetaminophen | pyrazolanthrone inhibits the reaction [[Acetaminophen co-treated with Quercetin] results in increased expression of GCLM mRNA] | 25881548 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of GCLM mRNA | 17562736 |
| D000082 | Acetaminophen | Acetaminophen promotes the reaction [Mifepristone results in increased activity of [GCLC protein binds to GCLM protein]] | 16840778 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of GCLM mRNA | 25818464 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of GCLM mRNA | 25499718|2932517 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of GCLM protein | 18468992 |
| D000082 | Acetaminophen | [GCLC protein binds to GCLM protein] which results in decreased susceptibility to Acetaminophen | 16840778 |
| D000082 | Acetaminophen | GCLM protein affects the susceptibility to Acetaminophen | 17584759 |
| D000082 | Acetaminophen | GCLM protein results in decreased susceptibility to Acetaminophen | 18642143 |
| D000082 | Acetaminophen | OGT gene mutant form promotes the reaction [Acetaminophen results in increased expression of GCLM mRNA] | 29325178 |
| D000082 | Acetaminophen | sulforafan inhibits the reaction [Acetaminophen results in decreased expression of GCLM mRNA] | 25818464 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of GCLM mRNA | 11245408|1720275 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of GCLM mRNA | 25818464 |
| D000082 | Acetaminophen | [GCLC protein co-treated with GCLM protein] affects the susceptibility to Acetaminophen | 17584759 |
| D000082 | Acetaminophen | sulforafan inhibits the reaction [Acetaminophen results in decreased expression of GCLM mRNA] | 25818464 |
| D000109 | Acetylcholine | GCLM gene SNP affects the susceptibility to Acetylcholine | 12975258 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of GCLM mRNA] | 19350554 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [elesclomol results in increased expression of GCLM mRNA] | 18723479 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenite results in increased expression of GCLM mRNA] | 19328227 |
| D000111 | Acetylcysteine | GCLM protein affects the susceptibility to Acetylcysteine | 17584759 |
| D000171 | Acrolein | Acrolein results in increased expression of GCLM mRNA | 24211530 |
| D000171 | Acrolein | Acrolein results in increased expression of GCLM mRNA | 12763045 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of GCLM mRNA | 28159594 |
| D020106 | Acrylamide | salvin inhibits the reaction [Acrylamide results in decreased expression of GCLM mRNA] | 28159594 |
| C010013 | adriamycinol | [GCLM gene mutant form results in increased metabolism of Doxorubicin] which results in increased abundance of adriamycinol | 25446851 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of GCLM mRNA | 19770486 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of GCLM mRNA | 23630614 |
| D000393 | Air Pollutants | Air Pollutants results in increased expression of GCLM mRNA | 23649983 |
| D000393 | Air Pollutants | Air Pollutants results in increased expression of GCLM protein | 23649983 |
| D000393 | Air Pollutants | GCLM gene mutant form promotes the reaction [Air Pollutants results in increased expression of IL3 protein] | 27865893 |
| D000393 | Air Pollutants | GCLM gene mutant form promotes the reaction [Air Pollutants results in increased expression of IL6 protein] | 27865893 |
| C000188 | alachlor | alachlor results in increased expression of GCLM protein | 14563481 |
| C496116 | alpha-damascone | alpha-damascone results in increased expression of GCLM mRNA | 27965148 |
| D024502 | alpha-Tocopherol | [alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLM mRNA | 24530478 |
| D024502 | alpha-Tocopherol | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] | 22389237 |
| D019804 | Mesalamine | Mesalamine promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mRNA] | 27818126 |
| D000638 | Amiodarone | Amiodarone affects the expression of GCLM mRNA | 25064622 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of GCLM mRNA | 16483693 |
| C018453 | ammonium hexachloroplatinate | ammonium hexachloroplatinate results in increased expression of GCLM mRNA | 24211530 |
| D000667 | Ampicillin | Ampicillin results in decreased expression of GCLM mRNA | 21632981 |
| D000667 | Ampicillin | Ampicillin results in increased expression of GCLM mRNA | 22609641 |
| C030419 | andrographolide | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GCLM mRNA | 19737545 |
| C030419 | andrographolide | andrographolide results in increased expression of GCLM mRNA | 25110055 |
| C030419 | andrographolide | andrographolide results in increased expression of GCLM protein | 25110055 |
| D000966 | Antimony Potassium Tartrate | Antimony Potassium Tartrate results in increased expression of GCLM mRNA | 28713220 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of GCLM mRNA | 24449571 |
| D047310 | Apigenin | Apigenin results in increased expression of GCLM mRNA | 22864849 |
| D047310 | Apigenin | [Apigenin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide | 22864849 |
| D047310 | Apigenin | Apigenin results in increased expression of GCLM protein | 22864849 |
| D016718 | Arachidonic Acid | Arachidonic Acid results in increased expression of GCLM mRNA | 16704987 |
| C015000 | arecaidine esters | arecaidine esters results in increased expression of GCLM mRNA | 22851183 |
| C015000 | arecaidine esters | arecaidine esters results in increased expression of GCLM mRNA | 22851183 |
| D001151 | Arsenic | Arsenic results in increased expression of GCLM mRNA | 19945496 |
| D001151 | Arsenic | Arsenic results in increased expression of GCLM protein | 18487201|2741310 |
| D001152 | Arsenicals | Arsenicals promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of GCLM mRNA] | 24632381 |
| C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of GCLM mRNA] | 19350554 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide results in increased expression of GCLM mRNA] | 23883479 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of GCLM protein | 25341331 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of GCLM mRNA | 15725085|1912883 |
| C006632 | arsenic trioxide | Ethionamide inhibits the reaction [arsenic trioxide results in increased expression of GCLM mRNA] | 26708503 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of GCLM promoter | 20810208 |
| C015001 | arsenite | arsenite results in increased expression of GCLM mRNA | 22476201|2568028 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of GCLM mRNA] | 22476201 |
| C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite results in increased expression of GCLM mRNA] | 22476201 |
| C015001 | arsenite | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [arsenite results in increased expression of GCLM mRNA] | 19328227 |
| C015001 | arsenite | Acetylcysteine inhibits the reaction [arsenite results in increased expression of GCLM mRNA] | 19328227 |
| C015001 | arsenite | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of GCLM mRNA | 15894712 |
| C015001 | arsenite | arsenite results in increased activity of [GCLC protein binds to GCLM protein] | 19328227 |
| C015001 | arsenite | arsenite results in increased expression of [GCLC protein binds to GCLM protein] | 19328227 |
| C015001 | arsenite | arsenite results in increased expression of GCLM mRNA | 15894712|1932822 |
| C015001 | arsenite | arsenite results in increased expression of GCLM protein | 19328227 |
| C015001 | arsenite | arsenite results in increased stability of GCLM mRNA | 19328227 |
| C015001 | arsenite | Cycloheximide inhibits the reaction [arsenite results in increased activity of [GCLC protein binds to GCLM protein]] | 19328227 |
| C015001 | arsenite | Cycloheximide inhibits the reaction [arsenite results in increased expression of [GCLC protein binds to GCLM protein]] | 19328227 |
| C015001 | arsenite | Cycloheximide inhibits the reaction [arsenite results in increased expression of GCLM mRNA] | 19328227 |
| C039726 | artesunate | GCLM mRNA results in decreased susceptibility to artesunate | 15796179 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of GCLM mRNA" | 15520183 |
| D017638 | Asbestos, Crocidolite | "[GCLC protein co-treated with GCLM protein] inhibits the reaction [Asbestos, Crocidolite results in increased expression of FOSL1 mRNA]" | 15520183 |
| D017638 | Asbestos, Crocidolite | "[GCLC protein co-treated with GCLM protein] inhibits the reaction [Asbestos, Crocidolite results in increased expression of FOS mRNA]" | 15520183 |
| D017638 | Asbestos, Crocidolite | "[GCLC protein co-treated with GCLM protein] inhibits the reaction [Asbestos, Crocidolite results in increased expression of JUNB mRNA]" | 15520183 |
| D017638 | Asbestos, Crocidolite | "[GCLC protein co-treated with GCLM protein] inhibits the reaction [Asbestos, Crocidolite results in increased expression of JUN mRNA]" | 15520183 |
| D017638 | Asbestos, Crocidolite | "GCLM protein inhibits the reaction [Asbestos, Crocidolite results in increased expression of FOSL1 mRNA]" | 15520183 |
| D017638 | Asbestos, Crocidolite | "GCLM protein inhibits the reaction [Asbestos, Crocidolite results in increased expression of JUNB mRNA]" | 15520183 |
| D001379 | Azathioprine | Azathioprine results in increased expression of GCLM mRNA | 18222062|2262364 |
| C051597 | Bandrowski's base | Bandrowski's base results in increased expression of GCLM mRNA | 20566472 |
| C416282 | BAY 11-7085 | BAY 11-7085 results in increased expression of GCLM mRNA | 22851183 |
| D001554 | Benzene | Benzene results in increased expression of GCLM mRNA | 21843810 |
| C029876 | benzidine | benzidine results in increased expression of GCLM mRNA | 26198647 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of GCLM mRNA | 19737606 |
| D019324 | beta-Naphthoflavone | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GCLM mRNA | 19737545 |
| D019817 | Benzoic Acid | Benzoic Acid results in increased expression of GCLM mRNA | 20566472 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of GCLM mRNA | 20064835|2010694 |
| D001564 | Benzo(a)pyrene | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of GCLM mRNA | 15894712 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene affects the reaction [GCLM gene mutant form results in decreased expression of FASN mRNA] | 24291350 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene affects the reaction [GCLM gene mutant form results in decreased expression of SREBF1 mRNA] | 24291350 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene inhibits the reaction [GCLM gene mutant form results in increased expression of SOD2 mRNA] | 24291350 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of GCLM mRNA | 22228805 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of GCLM mRNA | 15034205|1589471 |
| D001564 | Benzo(a)pyrene | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of GCLM mRNA | 25820237 |
| D001564 | Benzo(a)pyrene | GCLM gene mutant form promotes the reaction [Benzo(a)pyrene results in increased expression of GCLC mRNA] | 24291350 |
| D001564 | Benzo(a)pyrene | [GCLM gene mutant form results in decreased abundance of Glutathione] which results in decreased susceptibility to Benzo(a)pyrene | 24107266 |
| D001564 | Benzo(a)pyrene | GCLM gene mutant form results in decreased susceptibility to Benzo(a)pyrene | 24291350 |
| D001564 | Benzo(a)pyrene | GCLM gene mutant form results in increased susceptibility to Benzo(a)pyrene | 23135907|2827969 |
| D001564 | Benzo(a)pyrene | GCLM protein affects the susceptibility to Benzo(a)pyrene | 22253057 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of GCLM mRNA | 22300585 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GCLM mRNA" | 19150397 |
| D016227 | Benzoquinones | Benzoquinones analog results in increased expression of GCLM protein | 21651925 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GCLM mRNA | 20061341 |
| D004958 | Estradiol | Estradiol results in increased expression of GCLM mRNA | 20106945 |
| D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in increased expression of GCLM mRNA | 22154832 |
| D004958 | Estradiol | Estradiol results in increased expression of GCLM mRNA | 22154832 |
| D004958 | Estradiol | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] | 22389237 |
| D004958 | Estradiol | Estradiol affects the expression of GCLM mRNA | 22389237 |
| D024503 | beta-Tocopherol | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] | 22389237 |
| D001688 | Biological Products | Biological Products results in increased expression of GCLM mRNA | 23266269 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane results in increased expression of GCLM mRNA | 19188863 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane results in increased expression of GCLM protein | 19188863 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane results in increased expression of GCLM mRNA | 17535857 |
| D017438 | Bisphenol A-Glycidyl Methacrylate | Bisphenol A-Glycidyl Methacrylate results in increased expression of GCLM mRNA | 27965148 |
| C002791 | bismuth tripotassium dicitrate | bismuth tripotassium dicitrate results in increased expression of GCLM mRNA | 15912405 |
| C006780 | bisphenol A | bisphenol A affects the expression of GCLM mRNA | 21786754 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of GCLM mRNA | 26063408 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of GCLM mRNA | 25181051|2698221 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of GCLM gene | 28505145 |
| C006780 | bisphenol A | bisphenol A results in increased expression of GCLM | 20924222 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in decreased expression of GCLM mRNA | 26198647 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of GCLM mRNA | 21601586 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of GCLM mRNA | 21601586 |
| C032036 | bromobenzene | bromobenzene results in increased expression of GCLM mRNA | 12628495 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [[Lithocholic Acid results in increased expression of GCLM protein] which results in increased abundance of Glutathione] | 17724089 |
| D019328 | Buthionine Sulfoximine | [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]] | 22864849 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine results in increased expression of GCLM mRNA | 10978506|1901038 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of GCLM mRNA | 12414654|2341063 |
| D020122 | tert-Butylhydroperoxide | [Apigenin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide | 22864849 |
| D020122 | tert-Butylhydroperoxide | [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]] | 22864849 |
| D020122 | tert-Butylhydroperoxide | [chrysin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide | 22864849 |
| D002104 | Cadmium | Cadmium results in increased expression of GCLM mRNA | 21120746|2117241 |
| D002104 | Cadmium | Cadmium results in increased expression of GCLM mRNA | 25388156 |
| C028031 | cadmium acetate | cadmium acetate results in increased expression of GCLM protein | 29140578 |
| C028031 | cadmium acetate | Trehalose inhibits the reaction [cadmium acetate results in increased expression of GCLM protein] | 29140578 |
| D019256 | Cadmium Chloride | Cadmium Chloride promotes the reaction [NFE2L2 protein binds to GCLM promoter] | 26827822 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of GCLM protein | 26827822 |
| D019256 | Cadmium Chloride | NFE2L2 protein promotes the reaction [Cadmium Chloride results in increased expression of GCLM protein] | 26827822 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of GCLM mRNA | 25596134 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of GCLM mRNA | 20061341 |
| D019256 | Cadmium Chloride | NFE2L2 gene mutant form inhibits the reaction [Cadmium Chloride results in increased expression of GCLM protein] | 26827822 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of GCLM mRNA | 19010381 |
| D002185 | Cannabidiol | Cannabidiol results in increased expression of GCLM mRNA | 21542829 |
| C005563 | captax | captax results in increased expression of GCLM mRNA | 23999411|2421153 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of GCLM mRNA | 24752500|2597931 |
| D012721 | Carbaryl | Carbaryl results in increased expression of GCLM mRNA | 27829164 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of GCLM mRNA | 17484886 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of GCLM mRNA | 17484886|2747729 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of GCLM protein | 27477297 |
| D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM mRNA]] | 27477297 |
| D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM protein]] | 27477297 |
| D002251 | Carbon Tetrachloride | tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM mRNA] | 27477297 |
| D002251 | Carbon Tetrachloride | tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM protein] | 27477297 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of GCLM mRNA | 15963342 |
| C068623 | carnosol | carnosol results in increased expression of GCLM mRNA | 20116392 |
| C026690 | cerous chloride | cerous chloride results in decreased expression of GCLM mRNA | 28954213 |
| D002635 | Chenodeoxycholic Acid | Chenodeoxycholic Acid results in increased expression of GCLM protein | 17724089 |
| D002635 | Chenodeoxycholic Acid | [Chenodeoxycholic Acid results in increased expression of GCLM protein] which results in increased abundance of Glutathione | 17724089 |
| D002699 | Chlorambucil | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Chlorambucil | 10900222 |
| D002713 | Chlorine | [Ozone co-treated with Chlorine] results in decreased expression of GCLM mRNA | 18636392 |
| C004656 | chloroacetaldehyde | chloroacetaldehyde results in increased expression of GCLM mRNA | 25596134 |
| D002726 | Chlorogenic Acid | Chlorogenic Acid results in increased expression of GCLM mRNA | 29136249 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in increased expression of GCLM mRNA | 26272509 |
| C100187 | chloropicrin | chloropicrin results in increased expression of GCLM mRNA | 24211530 |
| D002737 | Chloroprene | Chloroprene results in increased expression of GCLM mRNA | 23125180 |
| D002746 | Chlorpromazine | Chlorpromazine affects the expression of GCLM mRNA | 25064622 |
| D002793 | Cholic Acids | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of GCLM mRNA | 27344345 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GCLM mRNA | 20938992 |
| C074702 | chromium hexavalent ion | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of GCLM mRNA | 25820237 |
| C043561 | chrysin | [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]] | 22864849 |
| C043561 | chrysin | chrysin results in increased expression of GCLM mRNA | 22864849 |
| C043561 | chrysin | [chrysin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide | 22864849 |
| C043561 | chrysin | chrysin results in increased expression of GCLM protein | 22864849 |
| C043561 | chrysin | MAPK1 protein affects the reaction [chrysin results in increased expression of GCLM protein] | 22864849 |
| C043561 | chrysin | NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLM protein] | 22864849 |
| C059262 | cidofovir | cidofovir results in increased expression of GCLM mRNA | 25596134 |
| C012843 | cinnamic aldehyde | [cinnamic aldehyde results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | 20351055 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in increased expression of GCLM mRNA | 17178418|2399941 |
| C020722 | cinnamyl alcohol | cinnamyl alcohol results in increased expression of GCLM mRNA | 20566472|2399941 |
| C073341 | citraconic acid | citraconic acid results in increased expression of GCLM mRNA | 27277809 |
| C073341 | citraconic acid | citraconic acid results in increased expression of GCLM protein | 27277809 |
| C007076 | citral | citral results in increased expression of GCLM mRNA | 27965148 |
| C028677 | clivorine | clivorine results in decreased expression of GCLM mRNA | 25881548 |
| C028677 | clivorine | pyrazolanthrone inhibits the reaction [Quercetin inhibits the reaction [clivorine results in decreased expression of GCLM mRNA]] | 25881548 |
| C028677 | clivorine | Quercetin inhibits the reaction [clivorine results in decreased expression of GCLM mRNA] | 25881548 |
| D004002 | Clodronic Acid | Clodronic Acid results in increased expression of GCLM mRNA | 25596134 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of GCLM protein | 16470657 |
| D003035 | Cobalt | [tungsten carbide co-treated with Cobalt] results in increased expression of GCLM mRNA | 23052192 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of GCLM mRNA | 24612858 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of GCLM mRNA | 19320972|2294125 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of GCLM mRNA | 24386269 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of GCLM protein | 24386269 |
| D003042 | Cocaine | Cocaine affects the expression of GCLM mRNA | 20187946 |
| C075384 | coniferaldehyde | coniferaldehyde results in increased expression of GCLM mRNA | 26275128 |
| D003300 | Copper | [NSC 689534 binds to Copper] which results in increased expression of GCLM mRNA | 20971185 |
| D003300 | Copper | [Organoselenium Compounds binds to Copper] which results in increased expression of GCLM mRNA | 25167922 |
| D003300 | Copper | Copper analog results in increased expression of GCLM protein | 23882024 |
| D003300 | Copper | Copper results in increased expression of GCLM protein | 23882024 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of GCLM mRNA | 19549813 |
| C030123 | coumarin | coumarin results in increased expression of GCLM mRNA | 18480146 |
| D003375 | Coumestrol | [Coumestrol co-treated with resveratrol] results in increased expression of GCLM mRNA | 19167446 |
| C013453 | cresidine | cresidine results in increased expression of GCLM mRNA | 26198647 |
| C029892 | cupric chloride | cupric chloride results in increased expression of GCLM mRNA | 17211630|2434327 |
| C030973 | cupric oxide | cupric oxide results in increased expression of GCLM mRNA | 24343273 |
| C030973 | cupric oxide | cupric oxide analog results in increased expression of GCLM protein | 23882024 |
| D003474 | Curcumin | Curcumin analog results in increased expression of GCLM mRNA | 23954767 |
| D003474 | Curcumin | Curcumin results in increased expression of GCLM mRNA | 17198877|1799999 |
| D003474 | Curcumin | Curcumin results in increased expression of GCLM protein | 19188863 |
| D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin analog results in increased expression of GCLM mRNA] | 23954767 |
| D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin results in increased expression of GCLM mRNA] | 23954767 |
| D003474 | Curcumin | Curcumin results in increased expression of GCLM mRNA | 17535857|1916857 |
| D003474 | Curcumin | Curcumin results in increased activity of [GCLC protein binds to GCLM protein] | 17602960 |
| D003474 | Curcumin | Curcumin results in increased expression of GCLM mRNA | 17602960 |
| D003474 | Curcumin | Curcumin results in increased expression of GCLM protein | 17602960|1833287 |
| C114438 | cyanidin 3-O-glucoside | cyanidin 3-O-glucoside promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mRNA] | 27818126 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [arsenite results in increased activity of [GCLC protein binds to GCLM protein]] | 19328227 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [arsenite results in increased expression of [GCLC protein binds to GCLM protein]] | 19328227 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [arsenite results in increased expression of GCLM mRNA] | 19328227 |
| D016572 | Cyclosporine | Cyclosporine affects the expression of GCLM mRNA | 25064622 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of GCLM mRNA | 20106945|2556210 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of GCLM mRNA | 11589784|2559613 |
| C515055 | darinaparsin | darinaparsin results in increased expression of GCLM mRNA | 19417148 |
| D003634 | DDT | DDT results in increased expression of GCLM mRNA | 26198647 |
| C017180 | decamethrin | decamethrin results in decreased expression of GCLM mRNA | 16737586 |
| C017180 | decamethrin | decamethrin results in increased expression of GCLM mRNA | 16758951 |
| D013759 | Dronabinol | Dronabinol results in increased expression of GCLM mRNA | 21542829 |
| D013759 | Dronabinol | Dronabinol results in decreased expression of GCLM mRNA | 17578508 |
| C479072 | delta-tocopherol | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] | 22389237 |
| D003703 | Demecolcine | Demecolcine results in decreased expression of GCLM mRNA | 23649840 |
| C050229 | demethoxycurcumin | demethoxycurcumin results in increased expression of GCLM mRNA | 19188863|2338626 |
| C050229 | demethoxycurcumin | demethoxycurcumin results in increased expression of GCLM protein | 19188863 |
| C050229 | demethoxycurcumin | demethoxycurcumin results in increased expression of GCLM mRNA | 17535857 |
| D003840 | Deoxycholic Acid | [Deoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | 17724089 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of GCLM mRNA] | 27941970 |
| D003958 | Diamide | Diamide results in increased expression of GCLM mRNA | 15115889 |
| D003958 | Diamide | Diamide results in increased expression of GCLM protein | 15115889 |
| D003976 | Diazinon | Diazinon results in increased expression of GCLM mRNA | 26198647 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of GCLM mRNA | 21266533 |
| D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in increased expression of GCLM mRNA | 24535708 |
| D002945 | Cisplatin | Cisplatin promotes the reaction [jinfukang results in increased expression of GCLM mRNA] | 27392435 |
| D002945 | Cisplatin | Cisplatin promotes the reaction [MYC protein binds to GCLM promoter] | 17628013 |
| D002945 | Cisplatin | Cisplatin results in increased expression of GCLM mRNA | 25450742|2559613 |
| D002945 | Cisplatin | jinfukang promotes the reaction [Cisplatin results in increased expression of GCLM mRNA] | 27392435 |
| D004008 | Diclofenac | Diclofenac affects the expression of GCLM mRNA | 24752500 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of GCLM mRNA | 18042831 |
| D004041 | Dietary Fats | GCLM results in increased susceptibility to Dietary Fats | 21967773 |
| C058705 | diethyl malate | diethyl malate affects the expression of GCLM mRNA | 24814887 |
| C058705 | diethyl malate | S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GCLM mRNA] | 24814887 |
| C014476 | diethyl maleate | diethyl maleate results in increased expression of GCLM mRNA | 25270620 |
| C014476 | diethyl maleate | diethyl maleate results in increased expression of GCLM mRNA | 10978506|1511588 |
| C014476 | diethyl maleate | diethyl maleate results in increased expression of GCLM protein | 15115889|2146525 |
| D004052 | Diethylnitrosamine | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLM mRNA | 16158176 |
| C015835 | dimethyl-4-toluidine | dimethyl-4-toluidine results in increased expression of GCLM mRNA | 27638505 |
| D000069462 | Dimethyl Fumarate | Dimethyl Fumarate results in increased expression of GCLM mRNA | 27277809 |
| D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GCLM mRNA] | 27277809 |
| D000069462 | Dimethyl Fumarate | Dimethyl Fumarate results in increased expression of GCLM protein | 27277809 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of GCLM mRNA | 20146380|2056647 |
| D004137 | Dinitrochlorobenzene | NFE2L2 protein affects the reaction [Dinitrochlorobenzene results in increased expression of GCLM mRNA] | 27965148 |
| D004139 | Dinitrofluorobenzene | Dinitrofluorobenzene results in increased expression of GCLM mRNA | 23999411 |
| D004147 | Dioxins | Dioxins affects the expression of GCLM mRNA | 20463971 |
| C062963 | diphenylcarboxylate | diphenylcarboxylate results in increased expression of GCLM mRNA | 27965148 |
| D004178 | Diquat | Diquat results in increased expression of GCLM mRNA | 21172416 |
| D004178 | Diquat | Diquat results in increased expression of GCLM mRNA | 16962985|2082654 |
| D004221 | Disulfiram | Disulfiram results in increased expression of GCLM mRNA | 20566472 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in increased expression of GCLM mRNA | 25545062 |
| D007851 | Dodecanol | Dodecanol analog results in increased expression of GCLM mRNA | 27965148 |
| C012301 | domoic acid | domoic acid results in increased expression of GCLM mRNA | 23315585 |
| C012301 | domoic acid | domoic acid results in increased expression of GCLM protein | 23315585 |
| C012301 | domoic acid | GCLM affects the susceptibility to domoic acid | 17804861 |
| C012301 | domoic acid | GCLM protein results in decreased susceptibility to domoic acid | 23315585 |
| C012301 | domoic acid | "[GCLM protein results in decreased susceptibility to domoic acid] which results in decreased susceptibility to 2,3-dimethoxy-1,4-naphthoquinone" | 23315585 |
| C012301 | domoic acid | [GCLM protein results in decreased susceptibility to domoic acid] which results in decreased susceptibility to Hydrogen Peroxide | 23315585 |
| C012301 | domoic acid | GCLM results in decreased susceptibility to domoic acid | 19200344 |
| D004298 | Dopamine | [GCLM gene mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Dopamine | 23704229 |
| D004317 | Doxorubicin | [GCLC protein co-treated with GCLM protein] promotes the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin] | 10900222 |
| D004317 | Doxorubicin | ABCC1 gene mutant form promotes the reaction [Doxorubicin results in increased expression of GCLM protein] | 26822305 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of GCLM protein | 26822305 |
| D004317 | Doxorubicin | GCLM gene mutant form results in increased metabolism of Doxorubicin | 25446851 |
| D004317 | Doxorubicin | [GCLM gene mutant form results in increased metabolism of Doxorubicin] which results in increased abundance of adriamycinol | 25446851 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of GCLM mRNA" | 23811387 |
| D015118 | Eicosapentaenoic Acid | [Eicosapentaenoic Acid co-treated with Lipopolysaccharides] results in increased expression of GCLM mRNA | 22169119 |
| D015118 | Eicosapentaenoic Acid | [Eicosapentaenoic Acid co-treated with procyanidin B3 co-treated with Lipopolysaccharides] results in increased expression of GCLM mRNA | 22169119 |
| C512195 | elesclomol | Acetylcysteine inhibits the reaction [elesclomol results in increased expression of GCLM mRNA] | 18723479 |
| C512195 | elesclomol | elesclomol results in increased expression of GCLM mRNA | 18723479 |
| C118739 | entinostat | entinostat results in increased expression of GCLM mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| D004791 | Enzyme Inhibitors | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GCLM protein | 23301498 |
| D004811 | Epichlorohydrin | Epichlorohydrin results in increased expression of GCLM mRNA | 24211530 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased expression of GCLM mRNA | 25585349 |
| C031365 | epomediol | [Ethinyl Estradiol co-treated with epomediol] results in increased activity of GCLM protein | 12071332 |
| C048498 | erdosteine | erdosteine results in increased expression of GCLM protein | 26193055 |
| D004976 | Ethacrynic Acid | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Ethacrynic Acid | 10900222 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of GCLM mRNA | 25064622 |
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with epomediol] results in increased activity of GCLM protein | 12071332 |
| D005000 | Ethionamide | Ethionamide inhibits the reaction [arsenic trioxide results in increased expression of GCLM mRNA] | 26708503 |
| C004919 | ethylene dimethacrylate | ethylene dimethacrylate results in increased expression of GCLM mRNA | 27965148 |
| D005047 | Etoposide | [GCLC protein co-treated with GCLM protein] promotes the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | 10900222 |
| D005047 | Etoposide | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Etoposide | 10900222 |
| D005054 | Eugenol | Eugenol results in increased expression of GCLM mRNA | 20566472|2619864 |
| D011345 | Fenofibrate | Fenofibrate results in increased expression of GCLM mRNA | 25596134 |
| D015073 | 2-Acetylaminofluorene | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLM mRNA | 16158176 |
| D005472 | Fluorouracil | GCLM protein affects the susceptibility to Fluorouracil | 16217747 |
| D005485 | Flutamide | Flutamide results in increased expression of GCLM mRNA | 24136188 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GCLM mRNA | 20938992 |
| D005557 | Formaldehyde | Formaldehyde results in decreased expression of GCLM mRNA | 23649840 |
| C069837 | fullerene C60 | fullerene C60 results in decreased expression of GCLM mRNA | 19167457 |
| D008299 | Maleic Anhydrides | Maleic Anhydrides results in increased expression of GCLM mRNA | 24211530 |
| D005688 | Galactosamine | "[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of GCLM mRNA" | 28887131 |
| D024504 | gamma-Tocopherol | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] | 22389237 |
| C106014 | gedunin | gedunin results in increased expression of GCLM mRNA | 17010675 |
| D019833 | Genistein | Genistein results in decreased expression of GCLM mRNA | 12075121 |
| D005897 | Glafenine | Glafenine results in decreased expression of GCLM mRNA | 24136188 |
| D005978 | Glutathione | Buthionine Sulfoximine inhibits the reaction [[Lithocholic Acid results in increased expression of GCLM protein] which results in increased abundance of Glutathione] | 17724089 |
| D005978 | Glutathione | [Chenodeoxycholic Acid results in increased expression of GCLM protein] which results in increased abundance of Glutathione | 17724089 |
| D005978 | Glutathione | GCLM gene SNP results in decreased chemical synthesis of and results in decreased abundance of Glutathione | 12975258 |
| D005978 | Glutathione | [Lithocholic Acid results in increased expression of GCLM protein] which results in increased abundance of Glutathione | 17724089 |
| D005978 | Glutathione | GCLM gene mutant form results in decreased abundance of Glutathione | 20417186|2370422 |
| D005978 | Glutathione | [GCLM gene mutant form results in decreased abundance of Glutathione] which results in decreased susceptibility to Benzo(a)pyrene | 24107266 |
| D005978 | Glutathione | [GCLM gene mutant form results in decreased abundance of Glutathione] which results in increased expression of CBR3 protein | 25446851 |
| D005978 | Glutathione | GCLM protein affects the metabolism of Glutathione | 22253057 |
| D005978 | Glutathione | GCLM protein affects the susceptibility to Glutathione | 17584759 |
| D005978 | Glutathione | GCLM protein inhibits the reaction [IKBKB protein mutant form results in decreased abundance of Glutathione] | 20159942 |
| D005978 | Glutathione | GCLM protein mutant form results in decreased abundance of Glutathione | 22253057 |
| D005978 | Glutathione | GCLM protein results in increased chemical synthesis of Glutathione | 22253057|2313590 |
| D005978 | Glutathione | Glutathione deficiency results in increased expression of GCLM mRNA | 15345336|2062111 |
| D005978 | Glutathione | [GCLC protein co-treated with GCLM protein] results in increased chemical synthesis of Glutathione | 17584759 |
| C071834 | glycidamide | glycidamide results in increased expression of GCLM mRNA | 17822822 |
| D006037 | Glyoxal | Glyoxal results in increased expression of GCLM mRNA | 27965148 |
| C511402 | Grape Seed Proanthocyanidins | Grape Seed Proanthocyanidins results in increased expression of GCLM mRNA | 20471814 |
| C412815 | GW 4064 | GW 4064 results in increased expression of GCLM mRNA | 26655953 |
| D055768 | Halogenated Diphenyl Ethers | GCLM protein results in decreased susceptibility to Halogenated Diphenyl Ethers | 19150461 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased expression of GCLM mRNA | 15159207 |
| C080043 | hexyl cinnamic aldehyde | hexyl cinnamic aldehyde results in increased expression of GCLM mRNA | 20566472 |
| D017313 | Fenretinide | Fenretinide results in increased expression of GCLM mRNA | 28973697 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of GCLM mRNA | 26846883 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of GCLM mRNA | 18951874|2927443 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of GCLM mRNA | 12414654|1990215 |
| D006861 | Hydrogen Peroxide | Saponins inhibits the reaction [Hydrogen Peroxide results in decreased expression of GCLM mRNA] | 29274434 |
| D006861 | Hydrogen Peroxide | [GCLM protein results in decreased susceptibility to domoic acid] which results in decreased susceptibility to Hydrogen Peroxide | 23315585 |
| C031927 | hydroquinone | hydroquinone results in increased expression of GCLM protein | 21059386 |
| D006997 | Hypochlorous Acid | Hypochlorous Acid results in increased expression of GCLM mRNA | 18156441 |
| D006997 | Hypochlorous Acid | Hypochlorous Acid results in increased expression of GCLM mRNA | 19376150 |
| D007052 | Ibuprofen | Ibuprofen results in increased expression of GCLM mRNA | 11909699|2559613 |
| D007069 | Ifosfamide | Ifosfamide results in increased expression of GCLM mRNA | 25596134 |
| D007213 | Indomethacin | Indomethacin results in increased expression of GCLM mRNA | 11909699 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GCLM mRNA | 25613284 |
| D007501 | Iron | Iron results in decreased expression of GCLM mRNA | 19073151 |
| D007501 | Iron | Ursodeoxycholic Acid inhibits the reaction [Iron results in decreased expression of GCLM mRNA] | 19073151 |
| C036643 | isoeugenol | isoeugenol results in increased expression of GCLM mRNA | 20566472|2399941 |
| D007529 | Isoflavones | Isoflavones results in increased expression of GCLM mRNA | 17374662 |
| D007545 | Isoproterenol | Isoproterenol results in decreased expression of GCLM mRNA | 21335049 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of GCLM mRNA | 20003209 |
| C544151 | jinfukang | Cisplatin promotes the reaction [jinfukang results in increased expression of GCLM mRNA] | 27392435 |
| C544151 | jinfukang | jinfukang promotes the reaction [Cisplatin results in increased expression of GCLM mRNA] | 27392435 |
| C410337 | K 7174 | K 7174 results in increased expression of GCLM mRNA | 24086573 |
| D007660 | Ketoprofen | Ketoprofen results in increased expression of GCLM mRNA | 11909699 |
| D019344 | Lactic Acid | Lactic Acid results in increased expression of GCLM mRNA | 20566472 |
| D007854 | Lead | GCLM gene polymorphism affects the abundance of Lead | 25728017 |
| C008261 | lead acetate | lead acetate results in increased expression of GCLM mRNA | 26498409 |
| C008261 | lead acetate | NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLM mRNA] | 26498409 |
| C008261 | lead acetate | lead acetate results in increased expression of GCLM mRNA | 25270620 |
| C052901 | lemongrass oil | lemongrass oil affects the expression of GCLM mRNA | 25976427 |
| C008281 | limonene | limonene results in increased expression of GCLM mRNA | 27965148 |
| D001556 | Lindane | Lindane results in increased expression of GCLM mRNA | 26198647 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of GCLM mRNA" | 28887131 |
| D008070 | Lipopolysaccharides | [Eicosapentaenoic Acid co-treated with Lipopolysaccharides] results in increased expression of GCLM mRNA | 22169119 |
| D008070 | Lipopolysaccharides | [Eicosapentaenoic Acid co-treated with procyanidin B3 co-treated with Lipopolysaccharides] results in increased expression of GCLM mRNA | 22169119 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the expression of GCLM mRNA | 22169119 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of GCLM mRNA | 19339665 |
| D008070 | Lipopolysaccharides | methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased expression of GCLM mRNA] | 19339665 |
| D008095 | Lithocholic Acid | Buthionine Sulfoximine inhibits the reaction [[Lithocholic Acid results in increased expression of GCLM protein] which results in increased abundance of Glutathione] | 17724089 |
| D008095 | Lithocholic Acid | Lithocholic Acid affects the expression of GCLM mRNA | 20146260 |
| D008095 | Lithocholic Acid | Lithocholic Acid affects the expression of GCLM protein | 20146260 |
| D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | 17724089 |
| D008095 | Lithocholic Acid | Lithocholic Acid results in increased expression of GCLM protein | 17724089 |
| D008095 | Lithocholic Acid | [Lithocholic Acid results in increased expression of GCLM protein] which results in increased abundance of Glutathione | 17724089 |
| D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | 17724089 |
| D047311 | Luteolin | Luteolin results in increased expression of GCLM mRNA | 22864849 |
| D047311 | Luteolin | Luteolin results in increased expression of GCLM protein | 22864849 |
| D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GCLM mRNA | 21641980 |
| D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCLM mRNA | 26378955 |
| D008315 | Malondialdehyde | GCLM gene polymorphism affects the abundance of Malondialdehyde | 25728017 |
| D008550 | Melatonin | 4-phenyl-2-propionamidotetraline inhibits the reaction [Melatonin inhibits the reaction [KL mutant form results in decreased expression of GCLM mRNA]] | 25550330 |
| D008550 | Melatonin | Melatonin inhibits the reaction [KL mutant form results in decreased expression of GCLM mRNA] | 25550330 |
| D008550 | Melatonin | SL 327 inhibits the reaction [Melatonin inhibits the reaction [KL mutant form results in decreased expression of GCLM mRNA]] | 25550330 |
| D015122 | Mercaptopurine | Mercaptopurine results in increased expression of GCLM mRNA | 18222062 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of GCLM mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| D008627 | Mercuric Chloride | Mercuric Chloride affects the expression of GCLM mRNA | 20353558 |
| D008627 | Mercuric Chloride | "[NOG protein co-treated with Mercuric Chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| D008627 | Mercuric Chloride | ABCC2 gene mutant form promotes the reaction [Mercuric Chloride results in increased expression of GCLM mRNA] | 24039982 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of GCLM mRNA | 24039982 |
| D008628 | Mercury | GCLM gene polymorphism affects the abundance of Mercury | 21925580 |
| D008628 | Mercury | GCLM polymorphism affects the metabolism of Mercury | 16961004 |
| D008628 | Mercury | GCLM protein affects the abundance of Mercury | 18560528 |
| D008628 | Mercury | Mercury results in decreased expression of GCLM mRNA | 19937285 |
| D008687 | Metformin | Metformin results in increased expression of GCLM mRNA | 25596134 |
| D008687 | Metformin | Metformin results in decreased expression of GCLM mRNA | 25596134 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GCLM mRNA | 20938992 |
| C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased expression of GCLM" | 21723306 |
| C008435 | methyldithiocarbamate | methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased expression of GCLM mRNA] | 19339665 |
| D008753 | Methylenebis(chloroaniline) | Methylenebis(chloroaniline) results in increased expression of GCLM mRNA | 26198647 |
| D008751 | Methylene Blue | [Methylene Blue co-treated with MAPT protein mutant form] results in increased expression of GCLM mRNA | 24556215 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of GCLM mRNA | 23179753|2627250 |
| C004925 | methylmercuric chloride | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of GCLM mRNA | 20061341 |
| D008767 | Methylmercury Compounds | GCLM protein affects the metabolism of Methylmercury Compounds | 18560528 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased expression of GCLM protein | 26558463 |
| D020366 | Methylmethacrylate | Methylmethacrylate results in increased expression of GCLM mRNA | 16916219 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of GCLM mRNA | 26011545 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of GCLM mRNA | 23649840 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased expression of GCLM protein | 26558463 |
| C033069 | methyl salicylate | methyl salicylate results in increased expression of GCLM mRNA | 20566472 |
| D015735 | Mifepristone | Acetaminophen promotes the reaction [Mifepristone results in increased activity of [GCLC protein binds to GCLM protein]] | 16840778 |
| D015735 | Mifepristone | Mifepristone results in increased activity of [GCLC protein binds to GCLM protein] | 16840778 |
| D015735 | Mifepristone | Mifepristone results in increased expression of GCLM protein | 16840778 |
| C517880 | monascin | monascin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA] | 23331247 |
| C517880 | monascin | NFE2L2 mutant form inhibits the reaction [monascin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA]] | 23331247 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of GCLM mRNA | 19945496 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of GCLM protein | 24625837 |
| C437683 | motexafin gadolinium | motexafin gadolinium results in increased expression of GCLM mRNA | 16357179 |
| C437683 | motexafin gadolinium | [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of GCLM mRNA | 16357179 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of GCLM protein" | 23026733 |
| D009285 | Naphthoquinones | Naphthoquinones results in increased expression of GCLM mRNA | 23811387 |
| D015058 | 1-Naphthylisothiocyanate | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of GCLM mRNA | 27344345 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of GCLM mRNA | 20551477 |
| D009288 | Naproxen | Naproxen results in increased expression of GCLM mRNA | 11909699 |
| C529068 | naringenin-7-O-glucoside | naringenin-7-O-glucoside results in increased expression of GCLM mRNA | 18652870 |
| C022794 | n-butyl glycidyl ether | n-butyl glycidyl ether results in increased expression of GCLM mRNA | 27965148 |
| C524653 | nectandrin-B | nectandrin-B results in increased expression of GCLM mRNA | 27511913 |
| C524653 | nectandrin-B | nectandrin-B results in increased expression of GCLM mRNA | 27511913 |
| C051752 | nefazodone | nefazodone results in increased expression of GCLM mRNA | 24136188 |
| C026385 | n-hexane | n-hexane results in increased expression of GCLM mRNA | 20566472 |
| D009532 | Nickel | Nickel results in increased expression of GCLM mRNA | 25583101 |
| C022838 | nickel chloride | nickel chloride results in increased expression of GCLM mRNA | 22110744 |
| C028007 | nickel monoxide | nickel monoxide results in decreased expression of GCLM mRNA | 19167457 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of GCLM mRNA | 16314067|2056647 |
| C012655 | nimesulide | nimesulide results in increased expression of GCLM mRNA | 24136188 |
| C077073 | nitisinone | [nitisinone results in decreased activity of HPD protein] which results in decreased expression of GCLM mRNA | 12899938 |
| D009569 | Nitric Oxide | GCLM gene SNP affects the abundance of and affects the activity of and affects the susceptibility to Nitric Oxide | 12975258 |
| D009585 | Nitrogen Dioxide | Nitrogen Dioxide results in decreased expression of GCLM mRNA | 16049373 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in decreased expression of GCLM mRNA | 17616710 |
| C014112 | N-methyl-4-aminophenol | N-methyl-4-aminophenol results in increased expression of GCLM mRNA | 27965148 |
| C002741 | N-nitrosomorpholine | N-nitrosomorpholine results in increased expression of GCLM protein | 19716841 |
| C010615 | Nonidet P-40 | Nonidet P-40 results in increased expression of GCLM mRNA | 26552463 |
| C570897 | NSC668394 | NSC668394 results in increased expression of GCLM mRNA | 27137931 |
| C558013 | NSC 689534 | [NSC 689534 binds to Copper] which results in increased expression of GCLM mRNA | 20971185 |
| C464660 | obeticholic acid | obeticholic acid results in increased expression of GCLM mRNA | 26655953 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of GCLM mRNA | 16251485|1841718 |
| D019787 | Linoleic Acid | Linoleic Acid metabolite results in increased expression of GCLM mRNA | 26879219 |
| D016627 | Oxidopamine | Oxidopamine results in decreased expression of GCLM protein | 25446857 |
| D016627 | Oxidopamine | salvin inhibits the reaction [Oxidopamine results in decreased expression of GCLM protein] | 25446857 |
| D016627 | Oxidopamine | Oxidopamine results in decreased expression of GCLM protein | 25446857 |
| D016627 | Oxidopamine | salvin inhibits the reaction [Oxidopamine results in decreased expression of GCLM protein] | 25446857 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in increased expression of GCLM mRNA | 18706400 |
| C016340 | o,p'-DDT | "o,p'-DDT affects the expression of GCLM mRNA" | 18925944 |
| C016340 | o,p'-DDT | "o,p'-DDT affects the expression of GCLM mRNA" | 17984292 |
| D016566 | Organoselenium Compounds | [Organoselenium Compounds binds to Copper] which results in increased expression of GCLM mRNA | 25167922 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in decreased expression of GCLM mRNA | 25729387 |
| C030110 | oxaliplatin | oxaliplatin results in decreased expression of GCLM mRNA | 25729387 |
| D010081 | Oxazolone | Oxazolone results in increased expression of GCLM mRNA | 23999411 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of GCLM mRNA | 25596134|2651600 |
| D010126 | Ozone | GCLM gene mutant form affects the susceptibility to Ozone | 20417186 |
| D010126 | Ozone | GCLM gene mutant form promotes the reaction [Ozone results in increased expression of MT1 mRNA] | 20417186 |
| D010126 | Ozone | GCLM gene mutant form promotes the reaction [Ozone results in increased expression of MT2 mRNA] | 20417186 |
| D010126 | Ozone | GCLM gene mutant form promotes the reaction [Ozone results in increased expression of SLC23A1 mRNA] | 20417186 |
| D010126 | Ozone | GCLM gene mutant form promotes the reaction [Ozone results in increased expression of SLC23A2 mRNA] | 20417186 |
| D010126 | Ozone | GCLM gene mutant form promotes the reaction [Ozone results in increased expression of SOD2 mRNA] | 20417186 |
| D010126 | Ozone | GCLM gene mutant form promotes the reaction [Ozone results in increased expression of TTPA mRNA] | 20417186 |
| D010126 | Ozone | [Ozone co-treated with Chlorine] results in decreased expression of GCLM mRNA | 18636392 |
| D000073878 | Palm Oil | Palm Oil results in decreased expression of GCLM mRNA | 18042831 |
| D010261 | Paraoxon | Paraoxon results in increased expression of GCLM mRNA | 24413757 |
| D010269 | Paraquat | Paraquat affects the expression of GCLM mRNA | 25064622 |
| D010269 | Paraquat | Paraquat results in increased expression of GCLM mRNA | 27288846 |
| D010269 | Paraquat | [alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLM mRNA | 24530478 |
| D010269 | Paraquat | GCLM gene mutant form results in increased susceptibility to Paraquat | 23704229 |
| D010269 | Paraquat | [GCLM gene mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Dopamine | 23704229 |
| D010269 | Paraquat | [GCLM gene mutant form results in increased susceptibility to Paraquat] which results in decreased activity of ACO2 protein | 23704229 |
| D010269 | Paraquat | Paraquat results in increased expression of GCLM mRNA | 28467894 |
| D052638 | Particulate Matter | GCLM gene mutant form affects the susceptibility to Particulate Matter | 23808636 |
| D052638 | Particulate Matter | GCLM gene mutant form promotes the reaction [Particulate Matter results in increased expression of IL3 protein] | 27865893 |
| D052638 | Particulate Matter | GCLM gene mutant form promotes the reaction [Particulate Matter results in increased expression of IL6 protein] | 27865893 |
| D052638 | Particulate Matter | GCLM protein results in decreased susceptibility to Particulate Matter | 21967497 |
| D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter results in increased expression of GCLM mRNA] | 18614404 |
| D052638 | Particulate Matter | Particulate Matter analog results in increased expression of GCLM mRNA | 15322212 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of GCLM mRNA | 18614404|2187364 |
| D010400 | Penicillin G | Penicillin G results in increased expression of GCLM mRNA | 22609641 |
| D010404 | Penicillin V | Penicillin V results in increased expression of GCLM mRNA | 22609641 |
| D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of GCLM mRNA | 23892564 |
| D010433 | Pentylenetetrazole | [Pentylenetetrazole co-treated with Vigabatrin] affects the expression of GCLM mRNA | 21503142 |
| C036567 | perfluorodecanoic acid | perfluorodecanoic acid results in increased expression of GCLM mRNA | 23567314 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of GCLM mRNA | 19159669 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of GCLM mRNA | 19162173 |
| D019800 | Phenol | Phenol results in increased expression of GCLM mRNA | 26198647 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of GCLM mRNA | 26272509 |
| D010672 | Phenytoin | Phenytoin results in increased expression of GCLM mRNA | 20345932 |
| D010695 | Phlorhizin | Phlorhizin results in decreased expression of GCLM mRNA | 22538082 |
| C018637 | phorone | phorone affects the expression of GCLM mRNA | 18198479 |
| D010705 | Phosgene | Phosgene affects the expression of GCLM mRNA | 16300373 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Spermidine results in increased expression of GCLM mRNA] | 12763045 |
| D010938 | Plant Oils | Plant Oils results in increased expression of GCLM mRNA | 23370395 |
| C014758 | plumbagin | plumbagin results in increased expression of GCLM mRNA | 20028456 |
| D011084 | Polycyclic Aromatic Hydrocarbons | Polycyclic Aromatic Hydrocarbons affects the expression of GCLM mRNA | 22579512 |
| C023617 | pregna-4,17-diene-3,16-dione | "pregna-4,17-diene-3,16-dione results in increased expression of GCLM mRNA" | 22851183 |
| C023617 | pregna-4,17-diene-3,16-dione | "pregna-4,17-diene-3,16-dione results in increased expression of GCLM mRNA" | 22851183 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in increased expression of GCLM mRNA | 19162173 |
| C479581 | procyanidin B3 | [Eicosapentaenoic Acid co-treated with procyanidin B3 co-treated with Lipopolysaccharides] results in increased expression of GCLM mRNA | 22169119 |
| D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in increased expression of GCLM mRNA | 22154832 |
| D019840 | 2-Propanol | 2-Propanol results in increased expression of GCLM mRNA | 20566472 |
| D054328 | Proton Pump Inhibitors | Proton Pump Inhibitors results in increased expression of GCLM mRNA | 25626140 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [[Acetaminophen co-treated with Quercetin] results in increased expression of GCLM mRNA] | 25881548 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Quercetin inhibits the reaction [clivorine results in decreased expression of GCLM mRNA]] | 25881548 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Quercetin results in increased expression of GCLM mRNA] | 25881548 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Quercetin results in increased expression of GCLM protein] | 25881548 |
| C432165 | pyrazolanthrone | pyrazolanthrone results in decreased activity of GCLM protein | 16972261 |
| D011794 | Quercetin | [Acetaminophen co-treated with Quercetin] results in increased expression of GCLM mRNA | 25881548 |
| D011794 | Quercetin | pyrazolanthrone inhibits the reaction [[Acetaminophen co-treated with Quercetin] results in increased expression of GCLM mRNA] | 25881548 |
| D011794 | Quercetin | pyrazolanthrone inhibits the reaction [Quercetin inhibits the reaction [clivorine results in decreased expression of GCLM mRNA]] | 25881548 |
| D011794 | Quercetin | pyrazolanthrone inhibits the reaction [Quercetin results in increased expression of GCLM mRNA] | 25881548 |
| D011794 | Quercetin | pyrazolanthrone inhibits the reaction [Quercetin results in increased expression of GCLM protein] | 25881548 |
| D011794 | Quercetin | Quercetin inhibits the reaction [clivorine results in decreased expression of GCLM mRNA] | 25881548 |
| D011794 | Quercetin | Quercetin results in increased expression of GCLM mRNA | 19576171|2163298 |
| D011794 | Quercetin | Quercetin results in increased expression of GCLM protein | 25881548 |
| D011794 | Quercetin | SB 203580 inhibits the reaction [Quercetin results in increased expression of GCLM mRNA] | 22197970 |
| D011794 | Quercetin | Quercetin analog results in increased activity of GCLM protein | 27777014 |
| D011794 | Quercetin | Quercetin results in increased expression of GCLM mRNA | 19183254 |
| D011794 | Quercetin | Quercetin results in increased expression of GCLM protein | 27777014 |
| C004532 | quinone | quinone results in increased expression of GCLM protein | 21059386 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased expression of GCLM mRNA | 25800948 |
| D017382 | Reactive Oxygen Species | [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]] | 22864849 |
| C059514 | resveratrol | [Coumestrol co-treated with resveratrol] results in increased expression of GCLM mRNA | 19167446 |
| C059514 | resveratrol | resveratrol promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mRNA] | 27818126 |
| C059514 | resveratrol | resveratrol results in increased expression of GCLM mRNA | 25808216 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of GCLM mRNA | 20436886 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of GCLM mRNA | 25572481|2559613 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of GCLM mRNA | 25596134 |
| D012402 | Rotenone | Rotenone affects the expression of GCLM mRNA | 23186747 |
| D012402 | Rotenone | Rotenone results in increased expression of GCLM mRNA | 17657281 |
| C085746 | rottlerin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA]] | 25895139 |
| C085746 | rottlerin | rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA] | 25895139 |
| C064116 | S-(1,1,2,2-tetrafluoroethyl)cysteine | "S-(1,1,2,2-tetrafluoroethyl)cysteine results in increased expression of GCLM mRNA" | 16678137 |
| C018381 | salvin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased expression of GCLM protein] | 26577515|2668657 |
| C018381 | salvin | NFE2L2 mutant form inhibits the reaction [salvin results in increased expression of GCLM protein] | 26577515 |
| C018381 | salvin | NFE2L2 protein promotes the reaction [salvin results in increased expression of GCLM protein] | 26686574 |
| C018381 | salvin | salvin inhibits the reaction [Acrylamide results in decreased expression of GCLM mRNA] | 28159594 |
| C018381 | salvin | salvin inhibits the reaction [Oxidopamine results in decreased expression of GCLM protein] | 25446857 |
| C018381 | salvin | salvin results in increased expression of GCLM protein | 26577515|2668657 |
| C018381 | salvin | salvin inhibits the reaction [Oxidopamine results in decreased expression of GCLM protein] | 25446857 |
| D012503 | Saponins | Saponins inhibits the reaction [Hydrogen Peroxide results in decreased expression of GCLM mRNA] | 29274434 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Quercetin results in increased expression of GCLM mRNA] | 22197970 |
| C042431 | S-ethyl glutathione | S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GCLM mRNA] | 24814887 |
| C040115 | shogaol | shogaol metabolite results in increased expression of GCLM protein | 25148906 |
| C040115 | shogaol | shogaol results in increased expression of GCLM protein | 25148906 |
| D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased expression of GCLM mRNA] | 22546375 |
| D012834 | Silver | Silver results in increased expression of GCLM mRNA | 22036727|2254637 |
| D012834 | Silver | Silver results in increased expression of GCLM mRNA | 27131904 |
| D012838 | Silymarin | NFE2L2 mutant form inhibits the reaction [Silymarin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA]] | 23331247 |
| D012838 | Silymarin | Silymarin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA] | 23331247 |
| D012838 | Silymarin | Silymarin results in increased expression of GCLM mRNA | 28137608 |
| D012838 | Silymarin | Silymarin results in increased expression of GCLM protein | 28137608 |
| C403258 | si-wu-tang | si-wu-tang results in increased expression of GCLM mRNA | 21464939 |
| C424127 | SL 327 | SL 327 inhibits the reaction [Melatonin inhibits the reaction [KL mutant form results in decreased expression of GCLM mRNA]] | 25550330 |
| C017947 | sodium arsenite | NFE2L1 protein affects the reaction [sodium arsenite results in increased expression of GCLM mRNA] | 20805060 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GCLM mRNA | 12679051|2010067 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GCLM protein | 27413109 |
| C017947 | sodium arsenite | [GCLM co-treated with GCLC] inhibits the reaction [sodium arsenite results in increased activity of and results in increased cleavage of CASP3 protein] | 20006689 |
| C017947 | sodium arsenite | [GCLM co-treated with GCLC] inhibits the reaction [sodium arsenite results in increased activity of CASP9 protein] | 20006689 |
| C017947 | sodium arsenite | GCLM gene mutant form results in increased susceptibility to sodium arsenite | 16014739 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GCLM mRNA | 16014739|2139691 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GCLM protein | 26371860 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of GCLM mRNA | 25625412 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GCLM mRNA | 21465251 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GCLM protein | 21465251 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of GCLM mRNA | 22155349 |
| C016104 | sodium bichromate | sodium bichromate results in increased expression of GCLM mRNA | 22155349 |
| D012967 | Sodium Dodecyl Sulfate | Sodium Dodecyl Sulfate results in increased expression of GCLM mRNA | 20566472 |
| D053260 | Soot | Soot results in increased expression of GCLM protein | 23065132 |
| D013095 | Spermidine | pimagedine inhibits the reaction [Spermidine results in increased expression of GCLM mRNA] | 12763045 |
| D013095 | Spermidine | Spermidine results in increased expression of GCLM mRNA | 12763045 |
| C539817 | S-sulindac | S-sulindac results in increased expression of GCLM mRNA | 19276279 |
| D019311 | Staurosporine | Staurosporine promotes the reaction [MYC protein binds to GCLM promoter] | 17628013 |
| D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GCLM mRNA | 21641980 |
| D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCLM mRNA | 26378955 |
| C016766 | sulforafan | sulforafan results in increased expression of GCLM | 21723306 |
| C016766 | sulforafan | sulforafan results in increased expression of GCLM mRNA | 20442190|2153938 |
| C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in increased expression of GCLM mRNA] | 20932822 |
| C016766 | sulforafan | sulforafan inhibits the reaction [Acetaminophen results in decreased expression of GCLM mRNA] | 25818464 |
| C016766 | sulforafan | sulforafan results in increased expression of GCLM mRNA | 19071154|1930389 |
| C016766 | sulforafan | sulforafan results in increased expression of GCLM protein | 19303893|2777701 |
| C016766 | sulforafan | sulforafan inhibits the reaction [Acetaminophen results in decreased expression of GCLM mRNA] | 25818464 |
| C016766 | sulforafan | sulforafan results in increased expression of GCLM mRNA | 25818464 |
| D013496 | Suprofen | Suprofen results in increased expression of GCLM mRNA | 11909699 |
| D013605 | T-2 Toxin | T-2 Toxin results in decreased expression of GCLM mRNA | 20854872 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of GCLM mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of GCLM mRNA | 11489354|1755586 |
| D013749 | Tetrachlorodibenzodioxin | GCLM results in decreased susceptibility to Tetrachlorodibenzodioxin | 22082335 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of GCLM mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in increased expression of GCLM mRNA | 25975270 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of GCLM mRNA | 18163543 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of GCLM mRNA | 21215274 |
| D013752 | Tetracycline | Tetracycline affects the expression of GCLM mRNA | 25064622 |
| D013755 | Tetradecanoylphorbol Acetate | 2-tert-butylhydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of GCLM mRNA] | 24632381 |
| D013755 | Tetradecanoylphorbol Acetate | Arsenicals promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of GCLM mRNA] | 24632381 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of GCLM mRNA | 24632381 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GCLM mRNA | 25613284 |
| C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM mRNA]] | 27477297 |
| C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM protein]] | 27477297 |
| C017953 | tetramethylpyrazine | tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM mRNA] | 27477297 |
| C017953 | tetramethylpyrazine | tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM protein] | 27477297 |
| D013853 | Thioacetamide | Thioacetamide affects the expression of GCLM mRNA | 25064622 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of GCLM mRNA | 10486302|1097850 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of GCLM protein | 10486302 |
| D008063 | Thioctic Acid | Thioctic Acid results in increased expression of GCLM mRNA | 16249512 |
| D013893 | Thiram | Thiram results in increased expression of GCLM mRNA | 23999411|2421153 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of GCLM mRNA | 22363418|2740439 |
| D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of GCLM mRNA] | 20133372 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of GCLM mRNA | 20133372 |
| D014050 | Toluene | Toluene results in increased expression of GCLM mRNA | 28245982 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in decreased expression of GCLM mRNA | 25729387 |
| D019772 | Topotecan | Topotecan results in decreased expression of GCLM mRNA | 25729387 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone results in increased expression of GCLM mRNA | 22851183 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone results in increased expression of GCLM mRNA | 22851183 |
| D014199 | Trehalose | Trehalose inhibits the reaction [cadmium acetate results in increased expression of GCLM protein] | 29140578 |
| C034613 | triacsin C | triacsin C results in increased expression of GCLM mRNA | 16704987 |
| C011559 | tributyltin | PRKCD gene mutant form promotes the reaction [tributyltin results in increased expression of GCLM mRNA] | 25895139 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased expression of GCLM mRNA | 19448997 |
| C012589 | trichostatin A | trichostatin A affects the expression of GCLM mRNA | 28542535 |
| C046488 | trimethyltin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA]] | 25895139 |
| C046488 | trimethyltin | rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA] | 25895139 |
| C046488 | trimethyltin | trimethyltin results in increased expression of GCLM mRNA | 25895139 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of GCLM mRNA | 22609641 |
| C050414 | tripterine | tripterine results in increased expression of GCLM mRNA | 17010675 |
| C013320 | tris(2-butoxyethyl) phosphate | GCLM protein results in decreased susceptibility to tris(2-butoxyethyl) phosphate | 25797475 |
| C002802 | tungsten carbide | [tungsten carbide co-treated with Cobalt] results in increased expression of GCLM mRNA | 23052192 |
| D014415 | Tunicamycin | Tunicamycin results in decreased expression of GCLM mRNA | 17127020 |
| C479548 | undecanal | undecanal analog results in increased expression of GCLM mRNA | 27965148 |
| C538763 | undecylenic acid | undecylenic acid results in increased expression of GCLM mRNA | 27965148 |
| D014580 | Ursodeoxycholic Acid | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid results in increased expression of GCLM mRNA] | 19073151 |
| D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid inhibits the reaction [Iron results in decreased expression of GCLM mRNA] | 19073151 |
| D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in increased expression of GCLM mRNA | 19073151 |
| C406224 | valdecoxib | valdecoxib results in increased expression of GCLM mRNA | 24136188 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of GCLM mRNA | 25064622 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of GCLM mRNA | 23179753|2438349 |
| C100058 | vanillin | vanillin results in increased expression of GCLM mRNA | 17178418 |
| D001335 | Vehicle Emissions | GCLM gene mutant form affects the susceptibility to Vehicle Emissions | 23808636 |
| D001335 | Vehicle Emissions | GCLM gene mutant form promotes the reaction [Vehicle Emissions results in increased expression of IL3 protein] | 27865893 |
| D001335 | Vehicle Emissions | GCLM gene mutant form promotes the reaction [Vehicle Emissions results in increased expression of IL6 protein] | 27865893 |
| D001335 | Vehicle Emissions | GCLM protein results in decreased susceptibility to Vehicle Emissions | 21967497 |
| D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions results in increased expression of GCLM mRNA] | 18614404 |
| D001335 | Vehicle Emissions | Vehicle Emissions analog results in increased expression of GCLM mRNA | 15322212 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of GCLM gene | 25560391 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of GCLM mRNA | 18614404 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of GCLM protein | 21920430 |
| D001335 | Vehicle Emissions | Vehicle Emissions analog results in increased expression of GCLM mRNA | 15541757 |
| D020888 | Vigabatrin | [Pentylenetetrazole co-treated with Vigabatrin] affects the expression of GCLM mRNA | 21503142 |
| D014750 | Vincristine | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Vincristine | 10900222 |
| D014750 | Vincristine | Vincristine results in decreased expression of GCLM mRNA | 23649840 |
| C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of GCLM mRNA | 26682919 |
| D014810 | Vitamin E | Vitamin E affects the expression of GCLM mRNA | 16298738|2044732 |
| D014810 | Vitamin E | Vitamin E affects the reaction [[REL binds to GCLM promoter] which affects the expression of GCLM mRNA] | 16298738|1629873 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased expression of GCLM mRNA | 12414654|2341063 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased expression of GCLM mRNA | 25270620 |
| D015032 | Zinc | Zinc deficiency results in decreased expression of GCLM mRNA | 23377617 |
| D015032 | Zinc | Zinc deficiency results in decreased expression of GCLM protein | 23377617 |
| D015032 | Zinc | Zinc deficiency results in decreased expression of GCLM mRNA | 23377617 |
| D015032 | Zinc | Zinc deficiency results in decreased expression of GCLM protein | 23377617 |
| D019345 | Zinc Acetate | [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of GCLM mRNA | 16357179 |
| D019345 | Zinc Acetate | Zinc Acetate results in increased expression of GCLM mRNA | 16357179 |
| C016837 | zinc chloride | zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLM mRNA] | 18385089 |